Current Cases

Truvada/TDF lawsuit TDF drugs are antiretrovirals used to treat HIV.  Gilead Sciences markets TDF in combination with other drugs under the brand name Truvada, as well as other names such as Atripla, Complera, Stribild, Symfi-Lo, Cimduo and Viread. Studies have found TDF drugs to be damaging to the kidneys and bones—dangers that were not properly disclosed […]

Read More
Protect Bioidenticals

Protect Bioidenticals

Millions of women rely on hormone replacement therapy to manage the symptoms of menopause. Hot flashes and night sweats affect two-thirds of all women as they transition into menopause, sometimes for years afterward, severely diminishing the quality of their lives. Unlike conventional hormone therapy that uses synthetic and animal-derived hormones that are different from a […]

Read More

Our Methodology

We wish to present the most accurate picture of the extent of the US Food and Drug Administration’s culpability in the number of serious adverse events—deaths in particular—connected to FDA-approved drugs and products. But to do that, we couldn’t rely solely on the government’s own data for one major reason: the problem of underreporting. For […]

Read More

Reform Healthcare

American health care is in crisis. It is bankrupting our country. Government regulations prevent consumers from choosing health insurance policies that fit their needs. If Americans are going to have sustainable, affordable health insurance, current policies must be reformed to allow a consumer-driven health insurance market to develop. But reforming health insurance policies isn’t enough. […]

Read More
Save CBD Oil

Save CBD Oil

We need to save this powerful pain reliever now. Action Alert! Without urgent grassroots support, hurting Americans could lose pivotal access to CBD oil, a key natural pain medication. Momentum is building on Capitol Hill, but our voices must be heard. In recent weeks we’ve been telling you about recent federal actions that threaten to […]

Read More
Congress: “More Crony Medicine, Please”

Congress: “More Crony Medicine, Please”

Lawmakers are on a course to put the FDA even deeper into the pocket of the pharmaceutical industry. Action Alert!  House and Senate leaders are looking to fast-track legislation that will reauthorize the Prescription Drug User Fee Act (PDUFA), the law that allows the US Food and Drug Administration to collect fees from pharmaceutical companies […]

Read More
In Pain? Feds Don’t Care!

In Pain? Feds Don’t Care!

Another key natural medicine to bite the dust? Action Alert! The Drug Enforcement Agency (DEA) is moving against cannabidiol (CBD), a supplement used to control pain and inflammation. The circumstances are extremely suspicious. Late last year, the DEA published a final rule that classifies marijuana and hemp extracts, including CBD, as Schedule 1 controlled substances—a […]

Read More
Here We Go Again: FDA Defies Congress

Here We Go Again: FDA Defies Congress

And hobbles your doctor. Action Alert! In the waning days of 2016, the US Food and Drug Administration (FDA) ignored the expressed will of Congress. The agency completed a “guidance” document that prohibits traditional compounding pharmacies from stocking doctors’ offices with custom drugs. In December 2015, Congress included a provision in an end-of-the-year spending bill […]

Read More
Good News on Lab Testing

Good News on Lab Testing

The FDA’s attack on independent lab testing appears to have been beaten back. Action Alert (Thank you to Congress) In a recent announcement, the US Food and Drug Administration (FDA) said that it will back off of its plans to put new rules in place for laboratory-developed tests (LDTs), rules that represented an attempted regulatory […]

Read More